Key Figures Q4 2003

Key Figures provide a succinct overview of the most significant developments for each period under review. You can view earlier quarters or years if you wish. Furthermore, you can find extensive reports by downloading press releases for the period of your choice.

Better-than-expected recovery of Q4 operating profit compared with Q3.
2003 operating profit EUR 294 million, down 23% from 2002 (ongoing activities)

• Integration and transformation of DSM Nutritional Products fully on schedule, immediate contribution to earnings per share.
• Q4 operating profit EUR 92 million.
• Profit on ordinary activities after taxation for 2003: EUR 219 million (-37%); fourth quarter EUR 60 million (-19%).
• Autonomous volume growth of 2% in 2003 compared with 2002.
• Dividend unchanged: EUR 1.75 per ordinary share.